Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Clinical trial NCT04395079 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04395079
Sponsor: Jonsson Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Female Reproductive System Neoplasm Platinum-Resistant Malignant Female Reproductive System Neoplasm Recurrent Malignant Female Reproductive System Neoplasm Refractory Malignant Female Reproductive System Neoplasm

Start date: 2020-08-07
Primary completion: 2024-10-11
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.